在AML中,中素反应是由一种类似于原始细胞的细胞状态所塑造的,这种细胞状态被SMAC模拟物选择性地准
Nona Struyf1, Henrik Gezelius2, Anders Lundmark2
1Department of Oncology-Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden. nona.struyf@ki.se.
NPJ precision oncology
|March 12, 2026
概括
FLT3突变的急性髓性白血病 (AML) 对中素的耐药性涉及特定的原始细胞样细胞群. 将中素与SMAC模仿剂结合起来,可以有效地准这种耐药AML亚群.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 发生FLT3突变的急性髓性白血病 (AML) 存在重大治疗挑战.
- 对FLT3抑制剂的耐药性,如中素,是临床的一个主要障碍.
研究的目的:
- 调查FLT3突变AML中中素耐药性的机制.
- 为了确定与治疗失败相关的特定白血病细胞种群.
- 探索新的治疗策略来克服抗药性.
主要方法:
- 多原子分析,包括单细胞和蛋白质组分析.
- 功能性药物测试和药物组合查.
- 基于表面标记物 (CD38,CD45RA) 的白血病细胞种群的表征.
主要成果:
- 鉴定出一种类似 CD38+CD45RA+原始细胞的白血病细胞群,与中素抵抗相关.
- 耐药细胞表现出改变的膜结构和从STAT5向PI3K/AKT的信号转移,促进生存.
- 与SMAC模拟剂共同向恢复了细胞亡,并选择性地耗尽了与中素结合时的耐药群体.
- 威尼托克拉克斯组合对CD34hi细胞产生了偏好的影响,突出了明显的亚种群脆弱性.
结论:
- 一种独特的耐药AML细胞表型,以特定的表面标记和信号通路为特征,有助于中素治疗失败.
- SMAC模仿组合是一种有希望的策略,通过准这种特定的白血病亚群来克服中素抵抗.
相关概念视频
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K


